Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
JAG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RPL10A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLTP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RPP40 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF37BP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ZNF562 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZFYVE28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DHX36 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAP2B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SRGAP2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ETFDH - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC25A23 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM168B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MVP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NLN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ESR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNPO2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ACSF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STAMBPL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IRF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on